KR100608415B1 - 폴리알킬렌 글리콜산 첨가제 - Google Patents
폴리알킬렌 글리콜산 첨가제 Download PDFInfo
- Publication number
- KR100608415B1 KR100608415B1 KR1020057001328A KR20057001328A KR100608415B1 KR 100608415 B1 KR100608415 B1 KR 100608415B1 KR 1020057001328 A KR1020057001328 A KR 1020057001328A KR 20057001328 A KR20057001328 A KR 20057001328A KR 100608415 B1 KR100608415 B1 KR 100608415B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- pag
- ester
- compound
- molecular weight
- Prior art date
Links
- 0 CC*(C)C(C1)CC1C(C[C@@]1C)=C1C1(C)*CCC1 Chemical compound CC*(C)C(C1)CC1C(C[C@@]1C)=C1C1(C)*CCC1 0.000 description 7
- LETYIFNDQBJGPJ-UHFFFAOYSA-N CCC1(C)CCCC1 Chemical compound CCC1(C)CCCC1 LETYIFNDQBJGPJ-UHFFFAOYSA-N 0.000 description 1
- HRSBIYASWAILIF-IENPIDJESA-N CCCC1C[C@@H](C)CC1 Chemical compound CCCC1C[C@@H](C)CC1 HRSBIYASWAILIF-IENPIDJESA-N 0.000 description 1
- QYCGHFOTMYKMIY-KKMMWDRVSA-N C[C@@H]1CC(C2)C2CC1 Chemical compound C[C@@H]1CC(C2)C2CC1 QYCGHFOTMYKMIY-KKMMWDRVSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/337—Polymers modified by chemical after-treatment with organic compounds containing other elements
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39813702P | 2002-07-24 | 2002-07-24 | |
| US60/398,137 | 2002-07-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20050025663A KR20050025663A (ko) | 2005-03-14 |
| KR100608415B1 true KR100608415B1 (ko) | 2006-08-02 |
Family
ID=31495718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057001328A KR100608415B1 (ko) | 2002-07-24 | 2003-07-16 | 폴리알킬렌 글리콜산 첨가제 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7193031B2 (pt-PT) |
| EP (1) | EP1526872A1 (pt-PT) |
| JP (2) | JP4451308B2 (pt-PT) |
| KR (1) | KR100608415B1 (pt-PT) |
| CN (1) | CN100337689C (pt-PT) |
| AR (1) | AR040654A1 (pt-PT) |
| AU (1) | AU2003258518B2 (pt-PT) |
| BR (1) | BR0313212A (pt-PT) |
| CA (1) | CA2492775C (pt-PT) |
| MX (1) | MXPA05000796A (pt-PT) |
| PL (1) | PL375265A1 (pt-PT) |
| RU (1) | RU2318004C2 (pt-PT) |
| WO (1) | WO2004012773A1 (pt-PT) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| EP2298278B1 (en) * | 2002-06-07 | 2015-11-11 | Dyax Corp. | Prevention and reduction of blood loss and inflammatory response |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| AU2003258518B2 (en) * | 2002-07-24 | 2007-01-18 | F. Hoffmann-La Roche Ag | Polyalkylene glycol acid additives |
| CA2537113A1 (en) * | 2003-08-29 | 2005-03-10 | Dyax Corp. | Modified protease inhibitors |
| PT1663281E (pt) * | 2003-08-29 | 2014-03-17 | Dyax Corp | Inibidores de proteases poli-peguilados |
| AU2005222641B2 (en) | 2004-03-15 | 2011-04-07 | Nektar Therapeutics | Polymer-based compositions and conjugates of HIV entry inhibitors |
| US20080255305A1 (en) * | 2004-05-17 | 2008-10-16 | Mcmaster University | Biological Molecule-Reactive Hydrophilic Silicone Surface |
| EP1768700B1 (en) | 2004-07-16 | 2010-12-15 | Nektar Therapeutics | Conjugates comprising gm-csf and a polymer |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| ATE425204T1 (de) * | 2005-08-26 | 2009-03-15 | Novo Nordisk As | Verfahren zur modifizierung eines makromolekularen systems |
| US8133707B2 (en) * | 2006-01-17 | 2012-03-13 | Enzon Pharmaceuticals, Inc. | Methods of preparing activated polymers having alpha nitrogen groups |
| AR067537A1 (es) * | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Purificacion de polipeptidos pegilados |
| AR067536A1 (es) | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea |
| US20090075887A1 (en) * | 2007-08-21 | 2009-03-19 | Genzyme Corporation | Treatment with Kallikrein Inhibitors |
| EP2331140B1 (en) | 2008-08-11 | 2018-07-04 | Nektar Therapeutics | Multi-arm polymeric alkanoate conjugates |
| AU2010203712A1 (en) | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
| RS62853B1 (sr) | 2010-01-06 | 2022-02-28 | Takeda Pharmaceuticals Co | Proteini koji vezuju kalikrein plazme |
| US10040761B2 (en) * | 2010-06-25 | 2018-08-07 | Nof Corporation | Branched hetero polyethylene glycol and intermediate |
| WO2012088445A1 (en) | 2010-12-22 | 2012-06-28 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds |
| US20130331443A1 (en) | 2010-12-22 | 2013-12-12 | Nektar Therapeutics | Multi-arm polymeric prodrug conjugates of taxane-based compounds |
| AU2012204202A1 (en) | 2011-01-06 | 2013-07-11 | Dyax Corp. | Plasma kallikrein binding proteins |
| KR102076874B1 (ko) | 2012-04-03 | 2020-02-12 | 쉰들러, 윌리엄 | 숙신이미드-활성화 나이트록실 화합물 및 단백질의 나이트록실화를 위한 이의 사용 방법 |
| CN102816227A (zh) * | 2012-08-30 | 2012-12-12 | 深圳赛保尔生物药业有限公司 | 回收促红细胞生成素的方法 |
| CN105188761B (zh) | 2013-03-15 | 2020-05-15 | 桑加特公司 | 聚环氧烷戊酸酯血红蛋白缀合物 |
| CN106459210A (zh) | 2014-03-27 | 2017-02-22 | 戴埃克斯有限公司 | 用于治疗糖尿病黄斑性水肿的组合物和方法 |
| US11286307B2 (en) | 2015-12-11 | 2022-03-29 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
| WO2020203583A1 (ja) * | 2019-03-29 | 2020-10-08 | 日油株式会社 | 末端カルボキシル基含有ポリエチレングリコールの製造方法および活性化ポリエチレングリコールの製造方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5849450B2 (ja) | 1975-07-09 | 1983-11-04 | 株式会社日立製作所 | スイリヨクシキカプセルユソウソウチノ ボウシクホウ |
| EP0206448B1 (en) * | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| JP2531661B2 (ja) | 1987-02-25 | 1996-09-04 | 味の素株式会社 | 酸素運搬剤 |
| US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
| US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
| DK0730470T3 (da) * | 1993-11-10 | 2002-06-03 | Enzon Inc | Forbedrede interferonpolymerkonjugater |
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| TW517067B (en) | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
| DK1157037T3 (da) | 1999-01-29 | 2003-11-24 | Hoffmann La Roche | GCSF-konjugater |
| WO2000051631A2 (en) | 1999-03-02 | 2000-09-08 | Schering Corporation | Pegylated alpha interferon for hiv therapy |
| CZ299516B6 (cs) | 1999-07-02 | 2008-08-20 | F. Hoffmann-La Roche Ag | Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem |
| AU781336B2 (en) | 1999-10-08 | 2005-05-19 | Nektar Therapeutics | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation |
| AU781839B2 (en) | 1999-12-22 | 2005-06-16 | Nektar Therapeutics | Sterically hindered derivatives of water soluble polymers |
| US20020065397A1 (en) | 2000-10-12 | 2002-05-30 | Joseph Roberts | Protecting therapeutic compositions from host-mediated inactivation |
| WO2002049673A2 (en) * | 2000-12-20 | 2002-06-27 | F. Hoffmann-La Roche Ag | Conjugates of erythropoietin (pep) with polyethylene glycol (peg) |
| AU2003258518B2 (en) * | 2002-07-24 | 2007-01-18 | F. Hoffmann-La Roche Ag | Polyalkylene glycol acid additives |
-
2003
- 2003-07-16 AU AU2003258518A patent/AU2003258518B2/en not_active Ceased
- 2003-07-16 KR KR1020057001328A patent/KR100608415B1/ko not_active IP Right Cessation
- 2003-07-16 MX MXPA05000796A patent/MXPA05000796A/es active IP Right Grant
- 2003-07-16 EP EP03766196A patent/EP1526872A1/en not_active Withdrawn
- 2003-07-16 BR BR0313212-9A patent/BR0313212A/pt not_active Application Discontinuation
- 2003-07-16 CA CA2492775A patent/CA2492775C/en not_active Expired - Fee Related
- 2003-07-16 CN CNB038175088A patent/CN100337689C/zh not_active Expired - Fee Related
- 2003-07-16 WO PCT/EP2003/007736 patent/WO2004012773A1/en active IP Right Grant
- 2003-07-16 JP JP2004525225A patent/JP4451308B2/ja not_active Expired - Fee Related
- 2003-07-16 RU RU2005105580/04A patent/RU2318004C2/ru not_active IP Right Cessation
- 2003-07-16 PL PL03375265A patent/PL375265A1/xx unknown
- 2003-07-22 AR AR20030102624A patent/AR040654A1/es not_active Application Discontinuation
- 2003-07-22 US US10/625,033 patent/US7193031B2/en not_active Expired - Fee Related
-
2006
- 2006-03-22 US US11/386,876 patent/US7504477B2/en not_active Expired - Fee Related
-
2008
- 2008-07-14 JP JP2008182692A patent/JP5112203B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009062516A (ja) | 2009-03-26 |
| BR0313212A (pt) | 2005-06-28 |
| KR20050025663A (ko) | 2005-03-14 |
| MXPA05000796A (es) | 2005-04-19 |
| PL375265A1 (en) | 2005-11-28 |
| WO2004012773A1 (en) | 2004-02-12 |
| US7504477B2 (en) | 2009-03-17 |
| CA2492775A1 (en) | 2004-02-12 |
| RU2318004C2 (ru) | 2008-02-27 |
| US20040106747A1 (en) | 2004-06-03 |
| EP1526872A1 (en) | 2005-05-04 |
| JP4451308B2 (ja) | 2010-04-14 |
| AR040654A1 (es) | 2005-04-13 |
| US7193031B2 (en) | 2007-03-20 |
| JP5112203B2 (ja) | 2013-01-09 |
| CN1671422A (zh) | 2005-09-21 |
| RU2005105580A (ru) | 2006-01-20 |
| CA2492775C (en) | 2011-06-21 |
| CN100337689C (zh) | 2007-09-19 |
| AU2003258518A1 (en) | 2004-02-23 |
| US20060167218A1 (en) | 2006-07-27 |
| AU2003258518B2 (en) | 2007-01-18 |
| JP2006502250A (ja) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100608415B1 (ko) | 폴리알킬렌 글리콜산 첨가제 | |
| JP4344110B2 (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
| US5990237A (en) | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines | |
| JP2859105B2 (ja) | インターフエロン抱合体 | |
| US20020072573A1 (en) | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation | |
| US8940801B2 (en) | Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation | |
| US20040034188A1 (en) | Novel monofunctional polyethylene glycol aldehydes | |
| EP1507755A2 (en) | Novel monofunctional polyethylene glycol aldehydes | |
| US20040122164A1 (en) | Novel monofunctional polyethylene glycol aldehydes | |
| US20030153694A1 (en) | Novel monofunctional polyethylene glycol aldehydes | |
| US20040147687A1 (en) | Novel monofunctional polyethylene glycol aldehydes | |
| KR100480432B1 (ko) | Ｇ-ｃｓｆ와 폴리에틸렌글리콜 유도체의 배합체 | |
| JP5953459B2 (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
| KR100480423B1 (ko) | 에리트로포이에틴과 폴리에틸렌글리콜 유도체의 배합체 | |
| KR100761652B1 (ko) | 단백질 또는 펩타이드에 결합되는 다가지의 고분자유도체와 접합체 | |
| JP2018115338A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
| JP2017197770A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
| JP2016029182A (ja) | ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法 | |
| WO2007078820A2 (en) | Methylmaleimidyl polymer derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20120628 Year of fee payment: 7 |
|
| FPAY | Annual fee payment |
Payment date: 20130628 Year of fee payment: 8 |
|
| LAPS | Lapse due to unpaid annual fee |